Held by 1 specialist biotech fund
Signal Note - ICICI Bank (IBN)
Driehaus Capital's $121.1M initiation in IBN signals conviction in Indian financial services exposure, though this represents a notable departure from their biotech-focused mandate. The position likely reflects macro positioning on India's banking sector rather than company-specific biotech catalysts, warranting clarity on whether this reflects portfolio rebalancing or a strategic shift in allocation strategy.
4 quarters